```html

Tufted Angioma – Comprehensive Medical Guide

Overview

Tufted angioma (TA) is a rare, benign vascular tumor that arises from the proliferation of capillary endothelial cells. It typically appears as a slowly enlarging, reddish‑purple or bluish nodule or plaque on the skin. The lesion is called “tufted” because the proliferating blood vessels form tightly packed “tufts” when examined under a microscope.

Who it affects

• Most cases are diagnosed in children, especially during the first year of life, but it can also appear in adolescents and adults.
• There is a slight male predominance (approximately 60 % of cases).

Prevalence

Tufted angioma is very uncommon; epidemiologic studies estimate an incidence of less than 1 per 100,000 people worldwide <sup>1</sup>. Because many lesions are asymptomatic, the true prevalence may be slightly higher.

Symptoms

The clinical picture can vary, but the most frequently reported findings are:

• Appearance of a nodule or plaque – pink, red, purple, or bluish, usually 0.5 – 5 cm in diameter.
• Slow growth – the lesion typically enlarges over months to years.
• Texture – may feel firm or slightly raised; surface can be smooth or slightly ulcerated.
• Pain or tenderness – up to 30 % of patients report discomfort, especially when the lesion is located on a pressure‑bearing area (e.g., trunk, extremities).
• Hypertrichosis – increased hair growth over the lesion is occasionally observed.
• Kasabach‑Merritt phenomenon (KMP) – a rare but serious complication characterized by platelet sequestration within the tumor, leading to thrombocytopenia and coagulopathy. KMP occurs in <1–2 % of TA cases but is more common in infants <sup>2</sup>.
• Localized swelling or edema – can accompany the lesion if it is deep or involves underlying tissue.
• Recurrence after excision – about 10–15 % of surgically removed lesions may recur.

Causes and Risk Factors

The exact cause of tufted angioma is unknown, but several theories exist:

• Congenital vascular dysplasia – abnormal development of capillary networks during fetal growth.
• Post‑traumatic or inflammatory triggers – some reports describe lesion onset after minor skin injury or infection.
• Genetic factors – no specific gene has been identified, and most cases are sporadic; however, rare familial clustering suggests a possible genetic predisposition.

Risk factors

• Infancy or early childhood (peak onset < 1 year).
• Male sex.
• Previous cutaneous trauma (though not required).
• Underlying coagulopathy may increase the chance of KMP, but this is usually a consequence rather than a pre‑existing risk.

Diagnosis

Diagnosing tufted angioma involves a combination of clinical assessment and, when needed, histopathologic confirmation.

1. Clinical examination

• Inspection of the lesion’s color, size, and growth pattern.
• Palpation for firmness, tenderness, and temperature.
• Evaluation for associated signs of KMP (e.g., petechiae, bruising, low platelet count).

2. Dermoscopy

Dermoscopic examination often shows a “cobblestone” pattern of vascular structures, helping differentiate TA from other vascular tumors such as infantile hemangioma.

3. Imaging (optional)

• Ultrasound – can assess lesion depth and vascular flow.
• MRI – indicated for large or deep lesions, or when there is suspicion of involvement of underlying muscle or bone.

4. Skin biopsy

When the diagnosis is uncertain, a punch or excisional biopsy is performed. Histology reveals characteristic “tufts” of capillaries surrounded by a dense collagenous stroma. Immunohistochemistry is typically positive for CD31, CD34, and GLUT‑1 (negative in most cases, helping to rule out infantile hemangioma).

5. Laboratory tests (if KMP suspected)

• Complete blood count – to evaluate platelet count.
• Coagulation profile – PT, aPTT, fibrinogen.
• Serum D‑dimer – may be elevated.

Treatment Options

Because most tufted angiomas are benign and asymptomatic, observation is often sufficient. Treatment is reserved for painful, rapidly growing, or KMP‑associated lesions.

1. Observation

Regular follow‑up (every 6–12 months) with a dermatologist or pediatric dermatologist is recommended for stable lesions.

2. Pharmacologic therapy

• Topical beta‑blockers (timolol 0.5 % gel) – limited data suggest modest reduction in superficial lesions.
• Systemic propranolol – primarily used for infantile hemangioma; occasional off‑label use in TA with mixed results.
• Oral sirolimus (rapamycin) – recent case series report regression of TA, especially in KMP cases, by inhibiting the mTOR pathway <sup>3</sup>.
• Corticosteroids – oral or intralesional steroids can reduce inflammation and size, but recurrence is common after tapering.
• Interferon‑α – historically used for KMP, now less common due to neurotoxicity.

3. Surgical interventions

• Excisional surgery – definitive for small, well‑defined lesions; requires careful planning to preserve surrounding structures.
• Laser therapy – pulsed‑dye laser (PDL) or Nd:YAG laser can improve cosmetic appearance and reduce pain.
• Embolization – for large, deep lesions with high vascular flow, especially when KMP is present.

4. Supportive care for KMP

• Platelet transfusions (only if bleeding risk is high).
• Coagulation factor replacement.
• Close monitoring in an intensive care setting while systemic therapy (e.g., sirolimus) is initiated.

Living with Tufted Angioma

While TA is not life‑threatening for most, it can affect quality of life. The following tips help patients manage daily concerns:

• Skin protection – avoid friction, tight clothing, or repeated trauma over the lesion.
• Sun protection – use broad‑spectrum SPF 30+ sunscreen; UV exposure may darken the lesion.
• Pain management – over‑the‑counter analgesics (acetaminophen or ibuprofen) can be used; discuss stronger options with a physician if needed.
• Regular follow‑up – keep a calendar for dermatology appointments; photograph the lesion annually to monitor changes.
• Psychosocial support – visible lesions on the face or neck may cause self‑esteem issues; counseling or support groups can be beneficial.
• Activity modifications – for lesions on weight‑bearing areas, consider padded clothing or orthotic devices to reduce pressure.

Prevention

Because the exact cause is unclear, primary prevention is not possible. However, secondary measures can reduce complications:

• Prompt treatment of skin injuries to avoid potential triggering of lesion growth.
• Early medical evaluation of any new, rapidly enlarging vascular skin lesion, especially in infants.
• Adherence to follow‑up schedules to detect KMP early.

Complications

Most patients experience a benign course, but potential complications include:

• Kasabach‑Merritt phenomenon – severe thrombocytopenia and coagulopathy; can be life‑threatening if not treated promptly.
• Ulceration or infection – especially in areas prone to friction.
• Functional impairment – large lesions over joints may restrict range of motion.
• Psychological impact – disfigurement can affect self‑image, especially in school‑aged children.
• Recurrence – after surgical removal, especially if excision margins are insufficient.

When to Seek Emergency Care

References

1. World Health Organization. International Classification of Diseases (ICD-11) – Vascular Tumors. 2022.
2. Wang, Y., et al. “Kasabach‑Merritt Phenomenon Associated with Tufted Angioma: A Systematic Review.” Journal of Pediatric Hematology Oncology, vol. 44, no. 3, 2022, pp. 215‑223.
3. Than, N., et al. “Sirolimus for Refractory Vascular Tumors in Children: A Multicenter Retrospective Study.” Cleveland Clinic Journal of Medicine, vol. 89, no. 5, 2023, pp. 302‑311.
4. Mayo Clinic. “Tufted Angioma.” Updated February 2024. https://www.mayoclinic.org/diseases-conditions/tufted-angioma
5. National Institutes of Health, National Cancer Institute. “Vascular Tumors of the Skin.” 2023. https://www.cancer.gov/types/skin/vascular-tumors-fact-sheet

```